Status:
ACTIVE_NOT_RECRUITING
Exercise Training to Atrial Fibrillation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
To test the impacts of different exercise training programs to the cardiopulmonary function, muscle metabolism, and body mass composition
Detailed Description
Atrial fibrillation (AF) has been a global threat due to its increasing incidence and prevalence, and also its potential complications of embolic stroke and heart failure, and therefore has a great im...
Eligibility Criteria
Inclusion
- Paroxysmal or persistent atrial fibrillation
- Daily activity below moderate intensity \< 300 minutes or high intensity \< 150 minutes per week.
Exclusion
- Active infection.
- Implant cardiac pacemaker.
- Uncontrolled hypertension.
- Cardiopulmonary contraindication to exercise training, such as decompensated heart failure, acute pulmonary edema, unstable angina, uncontrolled arrhythmia causing hemodynamic compromise, symptomatic severe aortic stenosis, suspected dissecting aortic aneurysm, severe pulmonary hypertension, acute myocarditis, endocarditis or pericarditis, uncontrolled asthma and SpO2 \< 90% at rest on room air.
- Inability to follow verbal command or to walk on treadmill or use stationary bike.
Key Trial Info
Start Date :
November 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04508478
Start Date
November 3 2021
End Date
December 31 2026
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan